Jiong Bi

3.3k total citations
51 papers, 2.5k citations indexed

About

Jiong Bi is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Jiong Bi has authored 51 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 21 papers in Oncology and 20 papers in Cancer Research. Recurrent topics in Jiong Bi's work include Cancer-related molecular mechanisms research (12 papers), MicroRNA in disease regulation (9 papers) and RNA modifications and cancer (8 papers). Jiong Bi is often cited by papers focused on Cancer-related molecular mechanisms research (12 papers), MicroRNA in disease regulation (9 papers) and RNA modifications and cancer (8 papers). Jiong Bi collaborates with scholars based in China, Hong Kong and United States. Jiong Bi's co-authors include Xiaohui Huang, Wen Li, Lianzhou Chen, Longjuan Zhang, Qiao Su, Jingsong Chen, Hao‐Xiang Tan, Ying Lin, Xin‐Yuan Guan and Xinhui Fu and has published in prestigious journals such as Nature Communications, Cancer Research and Biochemical and Biophysical Research Communications.

In The Last Decade

Jiong Bi

50 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jiong Bi China	27	1.7k	1.0k	594	265	228	51	2.5k
Xiaohu Tang United States	28	1.8k 1.0×	1.1k 1.0×	516 0.9×	281 1.1×	146 0.6×	40	2.4k
Enping Xu China	25	1.4k 0.8×	1.0k 1.0×	606 1.0×	246 0.9×	241 1.1×	49	2.3k
Anna M. Puzio‐Kuter United States	14	1.7k 1.0×	920 0.9×	606 1.0×	240 0.9×	145 0.6×	23	2.3k
Joseph Kwong Hong Kong	32	1.6k 1.0×	757 0.7×	803 1.4×	241 0.9×	476 2.1×	56	2.8k
Longjuan Zhang China	27	1.4k 0.8×	860 0.8×	462 0.8×	149 0.6×	190 0.8×	55	2.0k
Xuelai Luo China	29	1.6k 0.9×	768 0.8×	422 0.7×	250 0.9×	394 1.7×	62	2.2k
Ruth Birbe United States	29	1.5k 0.9×	1.1k 1.1×	707 1.2×	427 1.6×	248 1.1×	50	2.7k
Jianxin Jiang China	34	1.8k 1.1×	1.3k 1.2×	586 1.0×	197 0.7×	254 1.1×	99	2.6k
Xin Xu China	26	1.4k 0.8×	709 0.7×	758 1.3×	281 1.1×	222 1.0×	84	2.3k

Countries citing papers authored by Jiong Bi

Since Specialization

Citations

This map shows the geographic impact of Jiong Bi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiong Bi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiong Bi more than expected).

Fields of papers citing papers by Jiong Bi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiong Bi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiong Bi. The network helps show where Jiong Bi may publish in the future.

Co-authorship network of co-authors of Jiong Bi

This figure shows the co-authorship network connecting the top 25 collaborators of Jiong Bi. A scholar is included among the top collaborators of Jiong Bi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiong Bi. Jiong Bi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhao, Boyu, et al.. (2025). Expression and clinical significance of CD155, FGL1, Galectin-9, and PD‑L1 in breast cancer with neoadjuvant chemotherapy. Medical Oncology. 42(9). 375–375. 1 indexed citations

Dong, Shaowei, Jiayan Chen, Huahui Li, et al.. (2024). ATP6V0A1-dependent cholesterol absorption in colorectal cancer cells triggers immunosuppressive signaling to inactivate memory CD8+ T cells. Nature Communications. 15(1). 5680–5680. 19 indexed citations

Bai, Yang, et al.. (2024). miR-181c-5p/DERL1 pathway controls breast cancer progression mediated by TRAF6-linked K63 ubiquitination of AKT. Cancer Cell International. 24(1). 204–204. 1 indexed citations

Li, Tianfu, et al.. (2022). KIF17 maintains the epithelial phenotype of breast cancer cells and curbs tumour metastasis. Cancer Letters. 548. 215904–215904. 2 indexed citations

Li, Yuying, et al.. (2022). LINC01194 recruits NUMA1 to promote ubiquitination of RYR2 to enhance malignant progression in triple-negative breast cancer. Cancer Letters. 544. 215797–215797. 11 indexed citations

Li, Lei, Xu Chen, Qiao Su, et al.. (2020). DAPK3 inhibits gastric cancer progression via activation of ULK1-dependent autophagy. Cell Death and Differentiation. 28(3). 952–967. 55 indexed citations

Zhang, Qi, Si-Hong Lu, Tianfu Li, et al.. (2019). ACE2 inhibits breast cancer angiogenesis via suppressing the VEGFa/VEGFR2/ERK pathway. Journal of Experimental & Clinical Cancer Research. 38(1). 173–173. 212 indexed citations

Chen, Fan, Jiong Bi, Wen Li, et al.. (2018). Evaluation of the prognostic value of paraoxonase 1 in the recurrence and metastasis of hepatocellular carcinoma and establishment of a liver-specific predictive model of survival. Journal of Translational Medicine. 16(1). 327–327. 20 indexed citations

Su, Qiao, Haibo Liu, Dong Wang, et al.. (2018). Frizzled7 Promotes Epithelial-to-mesenchymal Transition and Stemness Via Activating Canonical Wnt/β-catenin Pathway in Gastric Cancer. International Journal of Biological Sciences. 14(3). 280–293. 98 indexed citations

10.

Wu, Jian‐Lin, Hai-Bo Qiu, Sui-Sui Dong, et al.. (2016). PSCA acts as a tumor suppressor by facilitating the nuclear translocation of RB1CC1 in esophageal squamous cell carcinoma. Carcinogenesis. 37(3). 320–332. 16 indexed citations

11.

Liang, Yan, Jiong Bi, Li Chen, et al.. (2014). REGγ regulates ERα degradation via ubiquitin–proteasome pathway in breast cancer. Biochemical and Biophysical Research Communications. 456(1). 534–540. 21 indexed citations

12.

Wu, Hongyu, Lihe Chen, Qiaoling Zhou, et al.. (2013). Aqp2-Expressing Cells Give Rise to Renal Intercalated Cells. Journal of the American Society of Nephrology. 24(2). 243–252. 65 indexed citations

13.

Kong, Kar Lok, Dora L.�W. Kwong, Li Fu, et al.. (2010). Characterization of a Candidate Tumor Suppressor Gene Uroplakin 1A in Esophageal Squamous Cell Carcinoma. Cancer Research. 70(21). 8832–8841. 38 indexed citations

14.

Fu, Xinhui, Qian Wang, Jingsong Chen, et al.. (2010). Clinical significance of miR-221 and its inverse correlation with p27Kip1 in hepatocellular carcinoma. Molecular Biology Reports. 38(5). 3029–3035. 62 indexed citations

15.

Bi, Jiong, Ailin Guo, Jiang F. Zhong, et al.. (2010). Overexpression of clusterin correlates with tumor progression, metastasis in gastric cancer: a study on tissue microarrays. Neoplasma. 57(3). 191–197. 41 indexed citations

16.

Chen, Jingsong, Qian Wang, Xinhui Fu, et al.. (2009). Involvement of PI3K/PTEN/AKT/mTOR pathway in invasion and metastasis in hepatocellular carcinoma: Association with MMP‐9. Hepatology Research. 39(2). 177–186. 292 indexed citations

17.

Chua, Daniel T. T., Jonathan S. T. Sham, Minyue Zhang, et al.. (2009). Increased expression of annexin I is associated with drug‐resistance in nasopharyngeal carcinoma and other solid tumors. PROTEOMICS - CLINICAL APPLICATIONS. 3(6). 654–662. 16 indexed citations

18.

Bi, Jiong, Liang Hu, Hui‐Lan Rao, et al.. (2008). Downregulation of ZIP kinase is associated with tumor invasion, metastasis and poor prognosis in gastric cancer. International Journal of Cancer. 124(7). 1587–1593. 28 indexed citations

19.

Fu, Xinhui, Qian Wang, Xilin Chen, et al.. (2008). Expression patterns and polymorphisms of PTCH in Chinese hepatocellular carcinoma patients. Experimental and Molecular Pathology. 84(3). 195–199. 11 indexed citations

20.

Zhang, Meng, et al.. (2006). Promoter Hypermethylation of a Novel Gene, ZHX2, in Hepatocellular Carcinoma. American Journal of Clinical Pathology. 125(5). 740–746. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact